Regulatory approval is next: Mizuho lifts Biogen to buy on news of Alzheimer’s drug success
admin Next stop regulatory approval. That was the view of analysts at Mizuho Securities, who late…
Read Moreregulatory
Amazon slashes its private-label selection, considers exiting business under regulatory pressure
Amazon.com Inc. has started drastically reducing the number of items it sells under its own…
Read More